Volume 16

  • No. 12 December 2019

    Reviews on the global burden of colorectal cancer, the influence of intestinal gases on gut disorders and metabolism in primary liver cancer, and commentaries on bowel prep and colorectal surgery, pancreatic cancer screening, and food intake regulation.

  • No. 11 November 2019

    Reviews on immunity in hepatitis B, pancreatic cysts and the gut microbiota in colorectal cancer, a Viewpoint on translating the gut microbiome to the clinic, and commentaries on empowering women early in their careers, living donor liver transplantation, colorectal cancer metastases and dual HCC–iCCA tumours.

  • No. 10 October 2019

    Reviews on the global burden and systemic therapy for hepatocellular carcinoma, probiotics and prebiotics and HBV infection kinetics, and commentaries on metabolic and bariatric surgery for adolescents, artificial intelligence and multi–omics in IBD.

  • No. 9 September 2019

    Reviews on paediatric NAFLD, intestinal macrophages and telomeres and telomerases in liver disease, and a Consensus Statement on terminology and definitions of colonic motility.

  • No. 8 August 2019

    Reviews on microbiota–gut–brain communication, acute pancreatitis and inherited biliary diseases, and commentaries on NAFLD, viral hepatitis and the small intestinal microbiome.

  • No. 7 July 2019

    Reviews on spatial heterogeneity in the liver, the progression of NASH to hepatocellular carcinoma, gastrointestinal diagnosis using capsule endoscopy, and commentaries on microbiome science, cellular diversity in the colon and platelets in NAFLD.

  • No. 6 June 2019

    Reviews on gut mycobiota in gastrointestinal disease, neonatal cholestasis and immunotherapy for colorectal cancer, a Perspective charting the history of NAFLD, and a commentary on microbial biofilms in colorectal cancer.

  • No. 5 May 2019

    Reviews on cholangiocyte pathobiology, big data in IBD, cancer-associated fibroblasts in gastrointestinal cancer, molecular phenotyping of IBD, and commentaries on faecal microbiota transplantation and mental health during pregnancy in women with IBD.

  • No. 4 April 2019

    Reviews on molecular subtypes of pancreatic cancer, alcoholic liver disease and the gut microbiota, fatigue in IBD, hepatic microcirculation and mechanisms of portal hypertension, and commentaries on food allergy, probiotics and precision dietary supplementation.

  • No. 3 March 2019

    Reviews on macrophages in NAFLD and NASH, PGC1s in liver metabolism and pathogenesis, pancreatitis epidemiology and prevention, IL-12, IL-23 and IL-17 in IBD, and commentaries on cell-based therapy for Crohn’s disease and trial end points in primary sclerosing cholangitis.

  • No. 2 February 2019

    Reviews on bioelectric neuromodulation for gastrointestinal disorders, redox signalling in the gut, Wnt–β-catenin signalling in the liver, and our Year in Review articles on the top 2018 scientific advances in viral hepatitis, colorectal cancer, NAFLD, IBD, liver regeneration and the gut microbiota.

  • No. 1 January 2019

    Reviews on microorganism influence on food sensitivities, intestinal stem cells, effects of diet on the gut microbiota, liver disease epidemiology in Asia, and commentaries on effects of HIV infection on the liver and HCV-positive organ transplantation.